Dian Diagnostics Group Co Ltd
SZSE:300244
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.96
27.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dian Diagnostics Group Co Ltd
Dian Diagnostics Group Co Ltd
PP&E Net
Dian Diagnostics Group Co Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
PP&E Net
¥1.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
29%
|
|
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
PP&E Net
¥443.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
PP&E Net
¥2.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
PP&E Net
¥3B
|
CAGR 3-Years
23%
|
CAGR 5-Years
29%
|
CAGR 10-Years
36%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
PP&E Net
¥3.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
PP&E Net
¥5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
44%
|
|
Dian Diagnostics Group Co Ltd
Glance View
Dian Diagnostics Group Co. Ltd. engages in the sale, outsourcing, research and development of medical diagnostic product and services. The company is headquartered in Hangzhou, Zhejiang and currently employs 11,123 full-time employees. The company went IPO on 2011-07-19. The firm's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The firm's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The firm's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.
See Also
What is Dian Diagnostics Group Co Ltd's PP&E Net?
PP&E Net
1.8B
CNY
Based on the financial report for Sep 30, 2024, Dian Diagnostics Group Co Ltd's PP&E Net amounts to 1.8B CNY.
What is Dian Diagnostics Group Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
29%
Over the last year, the PP&E Net growth was -6%. The average annual PP&E Net growth rates for Dian Diagnostics Group Co Ltd have been 4% over the past three years , 15% over the past five years , and 29% over the past ten years .
You don't have any saved screeners yet
